CWEGF yields 36.30% · PFE yields 6.13%● Live data
📍 CWEGF pulled ahead of the other in Year 1
Combined, CWEGF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CWEGF + PFE for your $10,000?
Crew Energy Inc. engages in the acquisition, exploration, development, and production of crude oil, natural gas, and natural gas liquids (NGL) in Canada. It primarily holds interests in Septimus, West Septimus, Groundbirch/Monias, Tower, and Attachie, areas located in the southwest, south, and west of Fort St. John in British Columbia. As of December 31, 2021, the West Septimus area had proved plus probable reserves of 51,559.2 thousand barrels (Mbbl) of NGL and 893,110 million cubic feet (Mmcf) of conventional natural gas; the Septimus area comprised of proved plus probable reserves of 4,257.6 Mbbl of light and medium crude oil, and 11,568.9 Mbbl of NGL along with 368,407 Mmcf of conventional natural gas; the Groundbirch/Monias area had total proved plus probable reserves of 9,500.5 Mbbl of NGL and 461,168 Mmcf of conventional natural gas; the Tower area comprised proved plus probable reserves of 1,599.2 Mbbl of light and medium crude oil, 619.2 Mbbl of NGL, and 23,364 Mmcf of conventional natural gas; and the Attachie area comprised proved plus probable reserves of 6,753.4 Mbbl of NGL and 164,970 Mmcf of conventional natural gas The company was incorporated in 2003 and is headquartered in Calgary, Canada.
Full CWEGF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.